Goldman Sachs’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Goldman Sachs’s Portfolio LVGO Stock Details LVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,242,346	Closed	-$174M	–	5875
2020 Q3	$174M	Buy	1,242,346 +957,545	+336%	+$117M	0.05%	375
2020 Q2	$21.4M	Buy	284,801 +88,534	+45%	+$4.63M	0.01%	1628
2020 Q1	$5.6M	Buy	196,267 +145,649	+288%	+$3.77M	﹤0.01%	2552
2019 Q4	$1.27M	Sell	50,618 -23,259	-31%	-$556K	﹤0.01%	3966
2019 Q3	$1.29M	Buy	+73,877	New	+$2.23M	﹤0.01%	3861

Goldman Sachs's LVGO Position: Q4 2020 in Review

Goldman Sachs sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 1,242,346 shares — an estimated $174M sold.

Goldman Sachs first reported a position in LVGO in Q3 2019 and held it in 5 quarters. The position peaked at $174M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

Goldman Sachs reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Goldman Sachs sold 1,242,346 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $174M.
Goldman Sachs first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
Goldman Sachs's Livongo Health, Inc. Common Stock position peaked at $174M in Q3 2020.
0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.